DIFFERENT PHARMACOLOGICAL RESPONSES OF ATRIUM AND VENTRICLE - STUDIES WITH HUMAN CARDIAC TISSUE

被引:36
作者
DU, XY
SCHOEMAKER, RG
BOS, E
SAXENA, PR
机构
[1] ERASMUS UNIV ROTTERDAM,FAC MED & HLTH SCI,CARDIOVASC RES INST COEUR,DEPT PHARMACOL,3000 DR ROTTERDAM,NETHERLANDS
[2] ERASMUS UNIV ROTTERDAM,FAC MED & HLTH SCI,CARDIOVASC RES INST COEUR,DEPT THORAC SURG,3000 DR ROTTERDAM,NETHERLANDS
关键词
ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN II; ATRIUM; CONTRACTILITY; ALPHA-CGRP (CALCITONIN GENE-RELATED PEPTIDE); SOMATOSTATIN; VENTRICLE; (HUMAN);
D O I
10.1016/0014-2999(94)90507-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been recently reported that 5-hydroxytryptamine (5-HT) increases force of contraction in atrial tissue but not in ventricular tissue. In the present study with trabeculae obtained from non-diseased human hearts, we investigated whether this difference in the contractile responses is specific for 5-HT or is also observed for other substances: calcitonin gene-related peptide (CGRP), angiotensin II, adenosine, somatostatin and acetylcholine. CGRP (10(-9) to 10(-7) M) and angiotensin II(10(-9) to 10(-5) M) caused concentration-dependent increases in force of contraction in atrial trabeculae (up to 36 +/- 8% and 42 +/- 8% of the response to 10(-5) M noradrenaline, respectively). Similar to 5-HT, no effects were observed with CGRP and angiotensin II in ventricular trabeculae. Adenosine (10(-8) to 10(-5) M) and somatostatin (10(-8) to 10(-6) M) caused concentration-dependent negative inotropic effects on baseline atrial contractility (-54 +/- 17% and -51 +/- 25%, respectively), but no response was found on baseline ventricular contractility. Adenosine, but not somatostatin, reduced force of contraction after pre-stimulation with 10(-5) M noradrenaline in atrial tissue and, to a lesser extent, in ventricular tissue. Acetylcholine exhibited a biphasic concentration-response curve in the atrial tissue, consisting of an initial negative inotropic response (10(-9) to 10(-7) M, from 120 +/- 41 mg at baseline to 48 +/- 16 mg at 10(-7) M), followed by a positive inotropic response (10(-6) to 10(-3) M, from 48 +/- 16 mg at 10(-7) M to 77 +/- 15 mg). On the baseline ventricular force of contraction, acetylcholine (10(-9) to 10(-4) M) induced only a positive inotropic effect, starting at 10(-9) M (from 252 +/- 65 mg at baseline to 353 +/- 71 mg at 10(-4) M). After pre-stimulation with 10(-5) M noradrenaline, acetylcholine reduced force of contraction in both tissues at 10(-3) M (atrium: - 14 +/- 4%, ventricle: -61 +/- 5%). The data indicate that, in atrial tissue, force of contraction can be affected by either positive or negative inotropic agents. However, in ventricular tissue only positive inotropic effects could be detected. Since atrial and ventricular tissues display different responses to the above biogenic substances, a different mechanism of regulation of contractility seems feasible.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 47 条
[1]   FUNCTIONAL EVIDENCE FOR THE EXISTENCE OF ADENOSINE RECEPTORS IN THE HUMAN-HEART [J].
BOHM, M ;
MEYER, W ;
MUGGE, A ;
SCHMITZ, W ;
SCHOLZ, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (03) :323-326
[2]   CHARACTERIZATION OF A1 ADENOSINE RECEPTORS IN ATRIAL AND VENTRICULAR MYOCARDIUM FROM DISEASED HUMAN HEARTS [J].
BOHM, M ;
PIESKE, B ;
UNGERER, M ;
ERDMANN, E .
CIRCULATION RESEARCH, 1989, 65 (05) :1201-1211
[3]   5-HYDROXYTRYPTAMINE-INDUCED TACHYCARDIA IN THE PIG - POSSIBLE INVOLVEMENT OF A NEW TYPE OF 5-HYDROXYTRYPTAMINE RECEPTOR [J].
BOM, AH ;
DUNCKER, DJ ;
SAXENA, PR ;
VERDOUW, PD .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (03) :663-671
[4]   HISTAMINE AND THE HUMAN-HEART - THE OTHER RECEPTOR SYSTEM [J].
BRISTOW, MR ;
GINSBURG, R ;
HARRISON, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (01) :249-251
[5]  
BRODDE OE, 1992, BASIC RES CARDIOL, V87, P1
[6]  
BROWN JH, 1984, J BIOL CHEM, V259, P3777
[7]   COMPARISON OF BUTYRYLCHOLINESTERASE AND ACETYLCHOLINESTERASE [J].
CHATONNET, A ;
LOCKRIDGE, O .
BIOCHEMICAL JOURNAL, 1989, 260 (03) :625-634
[8]  
DAY SM, 1985, BRIT HEART J, V53, P153
[9]   EFFECTS OF HISTAMINE ON PORCINE ISOLATED MYOCARDIUM - DIFFERENTIATION FROM EFFECTS ON HUMAN TISSUE [J].
DU, XY ;
SCHOEMAKER, RG ;
BAX, WA ;
BOS, E ;
SAXENA, PR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (03) :468-473
[10]  
DU XY, 1994, IN PRESS BR J PHARM